Correction ISI SCOPUS
Biochemical and Biophysical Research Communications  (2023)

Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium (vol 328, pg 133, 2022)

Omar, Intan Sofia; Adenan, Noor Azmi Mat; Godoy, Alejandro; Teo, Ik Hui; Gunasagran, Yogeeta; Chung, Ivy

Abstract

The authors would like to add details of the grant in the Acknowledgements as below: Acknowledgements This research was supported by Malaysian Ministry of Higher Education through Fundamental Research Grant Scheme (FRGS, FP029-2014B; grant code: FRGS/2/2014/SKK01/UM/02/1). This work was also supported by Universiti Malaya High Impact Research Grant (UM.C/625/HIR/MED/12) with no direct involvement in the conduct and writing of this study. The authors thank Universiti Malaya Tissue Biobank Unit and Translational Core Laboratory for supporting research activities. The authors would like to apologize for any inconvenience caused. © 2022 Elsevier Inc.

Más información

Título según WOS: Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium (vol 328, pg 133, 2022)
Título según SCOPUS: Corrigendum to “Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium” [Biochem. Biophys. Res. Commun. 628 (2022) 133–140, (S0006291X2201227X), (10.1016/j.bbrc.2022.08.088)]
Título de la Revista: Biochemical and Biophysical Research Communications
Volumen: 640
Editorial: Elsevier B.V.
Fecha de publicación: 2023
Página de inicio: 202
Idioma: English
DOI:

10.1016/j.bbrc.2022.12.065
Notas: ISI, SCOPUS